IO Biotech, Inc. (IOBT)
NASDAQ: IOBT · Real-Time Price · USD
0.3400
-0.0205 (-5.69%)
At close: Feb 20, 2026, 4:00 PM EST
0.3350
-0.0050 (-1.47%)
After-hours: Feb 20, 2026, 7:59 PM EST
IO Biotech Market Cap
IO Biotech has a market cap or net worth of $24.46 million as of February 20, 2026. Its market cap has decreased by -60.87% in one year.
Market Cap
24.46M
Enterprise Value
11.92M
1-Year Change
-60.87%
Ranking
Category
Stock Price
$0.34
Market Cap Chart
Since the IPO on November 5, 2021, IO Biotech's market cap has decreased from $369.28M to $24.46M, a decrease of -93.38%. That is a compound annual growth rate of -46.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 24.46M | -44.16% |
| Dec 31, 2025 | 43.81M | -27.72% |
| Dec 31, 2024 | 60.61M | -51.06% |
| Dec 29, 2023 | 123.86M | 86.88% |
| Dec 30, 2022 | 66.28M | -64.06% |
| Dec 31, 2021 | 184.42M | -50.06% |
| Nov 5, 2021 | 369.28M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cue Biopharma | 25.98M |
| Boundless Bio | 25.97M |
| Barinthus Biotherapeutics | 25.52M |
| Skye Bioscience | 25.05M |
| IGC Pharma | 24.93M |
| Marker Therapeutics | 24.18M |
| Daré Bioscience | 23.58M |
| Neuphoria Therapeutics | 23.45M |